INVESTOR RELATIONS
press release – price-sensitive
TURNOVER AS OF 31 DECEMBER 2025 AMOUNTING TO €4.6 MILLION, AN INCREASE OF 11.42% COMPARED TO THE SAME PERIOD IN 2024
TURNOVER AS OF 31 DECEMBER 2025 AMOUNTING TO €4.6 MILLION, AN INCREASE OF 11.42% COMPARED TO THE SAME PERIOD IN…TRANSFER OF SHARES BY MARIA GABRIELLA COLUCCI TO SMART CAPITAL
TRANSFER OF SHARES BY MARIA GABRIELLA COLUCCI TO SMART CAPITALARTERRA BIOSCIENCE S.P.A.: TURNOVER AT SEPTEMBER 30, 2025, APPROXIMATELY 3.6 MILLION EUROS
ARTERRA BIOSCIENCE S.P.A.: TURNOVER AT SEPTEMBER 30, 2025, APPROXIMATELY 3.6 MILLION EUROSARTERRA BIOSCIENCE ANNOUNCES THE SIGNING OF THE ADDENDUM TO THE VITALAB SHAREHOLDERS’ AGREEMENT
ARTERRA BIOSCIENCE ANNOUNCES THE SIGNING OF THE ADDENDUM TO THE VITALAB SHAREHOLDERS' AGREEMENTTHE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 2025
THE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 2025SUBSTANTIAL CHANGE IN OWNERSHIP STRUCTURE
SUBSTANTIAL CHANGE IN OWNERSHIP STRUCTUREARTERRA BIOSCIENCE S.P.A. HAS SOLD ITS ENTIRE STAKE IN THE SHARE CAPITAL OF LONGEVITY BIOSCIENCE S.R.L. EQUAL TO € 43,999.17
ARTERRA BIOSCIENCE S.P.A. HAS SOLD ITS ENTIRE STAKE IN THE SHARE CAPITAL OF LONGEVITY BIOSCIENCE S.R.L. EQUAL TO € 43,999.17ARTERRA BIOSCIENCE S.P.A. HAS SOLD ITS ENTIRE STAKE IN THE SHARE CAPITAL OF LONGEVITY BIOSCIENCE S.R.L.
ARTERRA BIOSCIENCE S.P.A. HAS SOLD ITS ENTIRE STAKE IN THE SHARE CAPITAL OF LONGEVITY BIOSCIENCE S.R.L.TURNOVER AT JUNE 30, 2025, APPROXIMATELY 2.6 MILLION EUROS
TURNOVER AT JUNE 30, 2025, APPROXIMATELY 2.6 MILLION EUROSSUBSTANTIAL CHANGE IN OWNERSHIP STRUCTURE
SUBSTANTIAL CHANGE IN OWNERSHIP STRUCTURE